The authors evaluated the efficacy and safety of S-1 plus oxaliplatin (SOX) as an alternative to cisplatin plus S-1 (CS) in first-line chemotherapy for advanced gastric cancer (AGC). SOX is as effective as CS for AGC with favorable safety profile, therefore SOX can replace CS.

READ FULL ARTICLE Curated publisher From Mdlinx